CPT’s Dr Richard Wyse Co-edits Prestigious Cochrane Report

CPT’s Dr Richard Wyse Co-edits Prestigious Cochrane Report
The Cure Parkinson’s Trust is honoured that our Director of Research, Dr Richard Wyse (above), is co-editor of a new Cochrane Report titled ‘GLP‐1 receptor agonists for Parkinson's disease’ - read the report here. The article explores the potential neuroprotective effects of GLP-1 receptor agonists (currently used to treat type 2 diabetes by stimulating the release of insulin) in conditions ... read more
Source: The Cure Parkinson’s TrustPublished on 2020-08-03